Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             373 results found
no title author magazine year volume issue page(s) type
1 341* ‘About Me’ adolescents introduce themselves to the adult CF team at transition Francis, J.
 2007
 6 S1 p. S83-
1 p.
 article
2 271* Achieving sustained compliance with nebulised therapies in a paediatric CF population McCormack, P.
 2007
 6 S1 p. S67-
1 p.
 article
3 325 Acupuncture in CF: is there a point? Scott, E.
 2007
 6 S1 p. S79-
1 p.
 article
4 231* Adiponectin levels and body composition of cystic fibrosis patients Panagopoulou, P.
 2007
 6 S1 p. S57-
1 p.
 article
5 10 Adult and atypical cystic fibrosis In Serbia Radojkovic, D.
 2007
 6 S1 p. S3-
1 p.
 article
6 123* AGE and sRAGE levels in cystic fibrosis Wilson, J.W.
 2007
 6 S1 p. S30-
1 p.
 article
7 4 Analysis of CFTR gene mutations in Moscow region Radionovitch, A.
 2007
 6 S1 p. S1-
1 p.
 article
8 179* Analysis of local flow and resistance in the lower airways in five children suffering from cystic fibrosis using computational fluid dynamics Vos, W.
 2007
 6 S1 p. S44-
1 p.
 article
9 362 Analytical characteristics of the Dynabio® pancreatitis associated protein (PAP) enzyme linked immunosorbent assay (ELISA) Wilde, H.M.
 2007
 6 S1 p. S88-
1 p.
 article
10 304 An assessment of needs towards the development of a non-malignant palliative care model Braithwaite, M.
 2007
 6 S1 p. S74-
1 p.
 article
11 74 Antibiotic resistance and hypermutator P. aeruginosa Waine, D.J.
 2007
 6 S1 p. S18-
1 p.
 article
12 57 Anti-IgE therapy for cystic fibrosis patients with difficulties in treating allergic bronchopulmonary aspergillosis Geidel, C.
 2007
 6 S1 p. S14-
1 p.
 article
13 305 Anxiety and depression: important factors in our understanding of quality of life Havermans, T.
 2007
 6 S1 p. S75-
1 p.
 article
14 245 A phase III trial of EUR-1008 in young cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI) Wooldridge, J.
 2007
 6 S1 p. S60-
1 p.
 article
15 253* A prospective randomized trial comparing airway clearance strategies following lung transplant Munro, P.
 2007
 6 S1 p. S62-
1 p.
 article
16 140 A prospective trial on the efficacy and tolerability of twice-daily dosing (TDD) versus once-daily dosing (ODD) amikacin in cystic fibrosis patients Postnikov, S.S.
 2007
 6 S1 p. S34-
1 p.
 article
17 315 Are the patient-reported outcomes (PROs) of value in annual review (AR) of adult patients with CF? Salek, M.S.
 2007
 6 S1 p. S77-
1 p.
 article
18 404 Are there any sex differences in lung function of CFTR – knock out mice? Bolle, I.
 2007
 6 S1 p. S99-
1 p.
 article
19 254* A retrospective analysis of physiotherapy input during a standard admission compared to a terminal admission in adults with CF Agent, P.
 2007
 6 S1 p. S63-
1 p.
 article
20 251 A retrospective analysis of various airways clearance techniques on FEV1 decline over one year in cystic fibrosis patients Mills, R.C.
 2007
 6 S1 p. S62-
1 p.
 article
21 208 A review of itraconazole use in a regional paediatric CF centre Gopal Kothandapani, J.S.
 2007
 6 S1 p. S51-
1 p.
 article
22 285 A second chronic illness: how do adults with CF experience being diagnosed with diabetes? Collins, S.
 2007
 6 S1 p. S70-
1 p.
 article
23 218 A snapshot audit of the dietary fruit and vegetable consumption in adults with cystic fibrosis (CF): How many portions are consumed daily? Chinuck, R.S.
 2007
 6 S1 p. S54-
1 p.
 article
24 180 Assessment of the impact of a dedicated multi disciplinary Healy, F.
 2007
 6 S1 p. S44-
1 p.
 article
25 171 Association between exhaled nitric oxide and disease severity in cystic fibrosis van Haren Noman, S.
 2007
 6 S1 p. S42-
1 p.
 article
26 165 Association in the mannose binding lectin (MBL) gene with severity of lung disease and survival in cystic fibrosis (CF) Castanos, C.M.
 2007
 6 S1 p. S40-
1 p.
 article
27 331 A survey of transition to the adult cystic fibrosis (CF) Centre at Papworth Hospital Murphy, C.
 2007
 6 S1 p. S81-
1 p.
 article
28 29 Attempts of facilitated trafficking ΔF508-CFTR to the plasma membrane Shityakov, S.W.
 2007
 6 S1 p. S7-
1 p.
 article
29 81 Audit of MRSA positive cultures at a UK adult CF centre Barker, H.C.
 2007
 6 S1 p. S20-
1 p.
 article
30 Author Index 2007
 6 S1 p. S101-S108
8 p.
 article
31 53 Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) – T1 expression and activity in CF airway epithelial cells Bergamini, G.
 2007
 6 S1 p. S13-
1 p.
 article
32 40* Aztreonam lysine for inhalation (AZLI) for CF patients with P. aeruginosa (PA) infection McCoy, K.
 2007
 6 S1 p. S10-
1 p.
 article
33 79 Bacterial contamination of PEP masks Jakobsson, B.M.
 2007
 6 S1 p. S19-
1 p.
 article
34 333 Basic structure of daily programme for patients with cystic fibrosis Stepankova, K.
 2007
 6 S1 p. S81-
1 p.
 article
35 131 Basophil activation test for the early diagnosis of allergic bronchopulmonary aspergillosis (ABPA) Katelari, A.
 2007
 6 S1 p. S32-
1 p.
 article
36 279 Benefits of aromatherapy massage for adult cystic fibrosis patients Haynes, F.
 2007
 6 S1 p. S69-
1 p.
 article
37 90 Binding of A549 cells by clinical isolates of P. aeruginosa Ryley, H.C.
 2007
 6 S1 p. S22-
1 p.
 article
38 60 Biocide resistance in the multidrug resistant cystic fibrosis pathogens Pseudomonas aeruginosa and Burkholderia cepacia complex Rose, H.
 2007
 6 S1 p. S15-
1 p.
 article
39 89 Biofilm formation by anaerobic bacteria isolated from the sputum of patients with Cystic Fibrosis Field, T.R.
 2007
 6 S1 p. S22-
1 p.
 article
40 278* BODE index and functional health status in cystic fibrosis patients Savci, S.
 2007
 6 S1 p. S69-
1 p.
 article
41 202 Bone health status in children with cystic fibrosis Kapustina, T.
 2007
 6 S1 p. S49-
1 p.
 article
42 189 Bowel habit audit in one regional adult CF centre Sobanska, A.
 2007
 6 S1 p. S46-
1 p.
 article
43 353 Breadth of disciplines attending international CF conferences Burhan, H.
 2007
 6 S1 p. S86-
1 p.
 article
44 98 Burkholderia pseudomallei in a cystic fibrosis (CF) patient in Brazil: an emerging pathogen? Hoffmann, A.
 2007
 6 S1 p. S24-
1 p.
 article
45 296 Can computers improve the in-patient experience? A survey of patients' views Frankcom, W.
 2007
 6 S1 p. S72-
1 p.
 article
46 313 Can patient-reported health-related quality of life predict survival in cystic fibrosis? Abbott, J.
 2007
 6 S1 p. S77-
1 p.
 article
47 250* Can physiological parameters determine the optimal method of airway clearance for the individual patient with cystic fibosis? McIlwaine, P.M.
 2007
 6 S1 p. S62-
1 p.
 article
48 233 Carotenoid supplementation in CF – How to find a way to do it safely? Sommerburg, O.
 2007
 6 S1 p. S57-
1 p.
 article
49 147 Categorization of patients by “Leeds criteria” for Pseudomonas aeruginosa infection in cystic fibrosis center in Republic of Macedonia Jakovska-Maretti, T.
 2007
 6 S1 p. S36-
1 p.
 article
50 139 Cefradine for anti-staphylococcal prophylaxis in children with cystic fibrosis Upadrasta, S.
 2007
 6 S1 p. S34-
1 p.
 article
51 292 CF and Me – a colouring book for children McDonald, R.
 2007
 6 S1 p. S71-
1 p.
 article
52 342 CF and sexuality fertility and reproduction: Is the nursing staff adequately educated to deal with issues of sexuality, fertility and reproduction related to CF patients Hattem van, M.
 2007
 6 S1 p. S83-
1 p.
 article
53 5 CFTR mutations detection in patients with cystic fibrosis from Romania using Elucigene CF29 kit Tamas, L.
 2007
 6 S1 p. S2-
1 p.
 article
54 84 Characterisation of fibrinogen degradation by the CF-related pathogens, Burkholderia cenocepacia and Pseudomonas aeruginosa Einarsson, G.G.
 2007
 6 S1 p. S21-
1 p.
 article
55 162 Characteristics of the patients with cystic fibrosis Uzuner, N.
 2007
 6 S1 p. S39-
1 p.
 article
56 263 Chest strength and mobility training: How do we do it? Demry, A.
 2007
 6 S1 p. S65-
1 p.
 article
57 145 Clinical correlates of hypermutator P. aeruginosa in CF Waine, D.J.
 2007
 6 S1 p. S35-
1 p.
 article
58 197 Clinical follow up after liver transplantation in children with cystic fibrosis Junge, S.
 2007
 6 S1 p. S48-
1 p.
 article
59 380* Clinical management system for cystic fibrosis Peckham, D.
 2007
 6 S1 p. S93-
1 p.
 article
60 346 Clinical manifestations of cystic fibrosis among patients diagnosed in childhood and patients diagnosed in adulthood Cobanoglu, N.
 2007
 6 S1 p. S84-
1 p.
 article
61 264 Clinical outcome and social parameters impact on sport activity in children with CF: a prospective survey Vital-Foucher, A.
 2007
 6 S1 p. S65-
1 p.
 article
62 97 Clostridium difficile colitis in transplanted cystic fibrosis patients. Theunissen, C.
 2007
 6 S1 p. S24-
1 p.
 article
63 386 Cochleotoxicity of systemically administered tobramycin in Cystic Fibrosis patients Scheenstra, R.J.
 2007
 6 S1 p. S94-
1 p.
 article
64 168* Combined lung and liver transplantation in cystic fibrosis Souilamas, R.
 2007
 6 S1 p. S41-
1 p.
 article
65 107 Comparison of 6 culture media, 5 DNA-extraction methods and PCR and nested PCR for sensitive detection of P. aeruginosa from CF sputa Schelstraete, P.
 2007
 6 S1 p. S26-
1 p.
 article
66 241 Comparison of inpatient blood glucose monitoring with UK Cystic Fibrosis Trust Guidelines Robb, L.
 2007
 6 S1 p. S59-
1 p.
 article
67 153 Comparison of lung function tests (LFT) in infants with CF and healthy subjects (HS) Tancredi, G.
 2007
 6 S1 p. S37-
1 p.
 article
68 78 Comparison of pathogen prevalence in CF patients treated at the Children's Memorial Health Institute in years 1999–2002 and 2003–2006 Dmenska, H.
 2007
 6 S1 p. S19-
1 p.
 article
69 308 Comparison of sleep quality, anxiety and depression between mothers of children with cystic fibrosis and with asthma Yilmaz, O.
 2007
 6 S1 p. S75-
1 p.
 article
70 80 Comparison of the bacterial communities sampled from the healthy and the cystic fibrosis lung Stressmann, F.A.
 2007
 6 S1 p. S20-
1 p.
 article
71 230 Comparison of three methods to measure body composition in patients with cystic fibrosis. Relation with retrotricipital skinfold thickness and brachial circumference Beaumesnil, M.
 2007
 6 S1 p. S57-
1 p.
 article
72 95* Comparison of T-RFLP profiles generated directly from sputum with those generated from conventional culture plates Rogers, G.B.
 2007
 6 S1 p. S23-
1 p.
 article
73 393 Complex CF facultative classes at the University of Medical Sciences, Poznan, Poland Krzyzanowski, M.
 2007
 6 S1 p. S96-
1 p.
 article
74 137 Concordance between intravenous antibiotics (IV) and in vitro susceptibility of sputum bacteria does not influence the outcome of pulmonary exacerbations in adult cystic fibrosis patients Jarad, N.A.
 2007
 6 S1 p. S33-
1 p.
 article
75 198 Consideration on ursodeoxicholic acid treatment Popa, I.
 2007
 6 S1 p. S48-
1 p.
 article
76 125 CRITICAL role for cytosolic phospholipase A2 in bronchial mucus hyper-secretion in CFTR-/- mice Dif, F.
 2007
 6 S1 p. S31-
1 p.
 article
77 396 CT scans from CF patients screened for lung transplant; the Severe Advance Lung Disease (SALD) CT scoring system Loeve, M.
 2007
 6 S1 p. S97-
1 p.
 article
78 385 Cutaneous phototoxicity secondary to ciprofloxacin in adult patients with cystic fibrosis: incidence and association with genotype Tolland, J.P.
 2007
 6 S1 p. S94-
1 p.
 article
79 375 Cystic fibrosis, apple peel disease and normal neonatal trypsin Repetto, T.
 2007
 6 S1 p. S92-
1 p.
 article
80 350 Cystic fibrosis (CF) and the risk of pancreatic cancer (PDAC) Lowenfels, A.
 2007
 6 S1 p. S85-
1 p.
 article
81 365 Cystic fibrosis newborn screening in the Czech Republic: overview of a pilot study Balascakova, M.
 2007
 6 S1 p. S89-
1 p.
 article
82 370 Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis Wilschanski, M.
 2007
 6 S1 p. S90-
1 p.
 article
83 322 Danish lung transplanted CF patients connection to the labour market prior to and after the transplantation Lund, L.D.
 2007
 6 S1 p. S78-
1 p.
 article
84 400 Decreased bone mineral density in adolescents and young adults with cystic fibrosis: prevalence and risk factors Jourdain, A.
 2007
 6 S1 p. S98-
1 p.
 article
85 188 Delayed gastric emptying is associated with lower BMI in adults with cystic fibrosis King, S.J.
 2007
 6 S1 p. S45-
1 p.
 article
86 46* Deposition and pharmacokinetic studies with inhaled P2Y2 agonists – evidence of high lung delivery and minimal systemic exposure Kellerman, D.
 2007
 6 S1 p. S11-
1 p.
 article
87 88* Detection of anaerobic bacteria in high numbers in sputum from Cystic Fibrosis patients with an acute exacerbation of pulmonary infection Moriarty, T.F.
 2007
 6 S1 p. S22-
1 p.
 article
88 260 Determinants of anaerobic performance in cystic fibrosis patients Inal-Ince, D.
 2007
 6 S1 p. S64-
1 p.
 article
89 160 Determinants of delivered dose from the I-neb® AAD® System Potter, R.W.
 2007
 6 S1 p. S39-
1 p.
 article
90 297* Developing patient information material: a collaborative effort McDonald, R.
 2007
 6 S1 p. S73-
1 p.
 article
91 106 Development of a diagnostic multiplex PCR test for the identification of three CF epidemic strains of Pseudomonas aeruginosa Fothergill, J.L.
 2007
 6 S1 p. S26-
1 p.
 article
92 310 Development of a unidimentional health status measure for cystic fibrosis (CF) Scott, S.F.
 2007
 6 S1 p. S76-
1 p.
 article
93 8 DHPLC in Cystic Fibrosis diagnostics in the German population Froster, U.
 2007
 6 S1 p. S2-
1 p.
 article
94 290 Diagnosis – how does it feel? Lambert, C.
 2007
 6 S1 p. S71-
1 p.
 article
95 212 Dietary treatment in adult patients with cystic fibrosis related diabetes Hollander, F.M.
 2007
 6 S1 p. S52-
1 p.
 article
96 15 Differences in lung function and physical performance in children with CF: the effect of ACE polymorphisms Slieker, M.G.
 2007
 6 S1 p. S4-
1 p.
 article
97 93* Different genetic adaptation strategies of mucoid and non-mucoid Pseudomonas aeruginosa in the airway of cystic fibrosis patients Lee, B.
 2007
 6 S1 p. S23-
1 p.
 article
98 35* Disruption of CFTR-dependent Lung and Intestine Organogenesis Results in Adult-Onset Diseases Cohen, J.C.
 2007
 6 S1 p. S8-
1 p.
 article
99 211 Does an integrated clinical and nutritional approach prevent pre-diabetic decline? White, H.
 2007
 6 S1 p. S52-
1 p.
 article
100 187 Does fundoplication reduce the decline in lung function and frequency of IV antibiotics in CF adults? Page, G.
 2007
 6 S1 p. S45-
1 p.
 article
101 143 Does increased frequency of sputum sampling alter antibiotic choice during exacerbations? Boyle, L.R.
 2007
 6 S1 p. S35-
1 p.
 article
102 26* Does male fertility impairment due to idiopathic semen hyperviscosity depend on CFTR gene mutations? Lucarelli, M.
 2007
 6 S1 p. S6-
1 p.
 article
103 221* Do overweight and obesity improve clinical outcome in the French cystic fibrosis population? Munck, A.
 2007
 6 S1 p. S54-
1 p.
 article
104 11 Do people with Cystic Fibrosis (CF) and one R117H allele have less severe phenotype compared with ΔF508 homozygotes? Shimmin, D.
 2007
 6 S1 p. S3-
1 p.
 article
105 115 Dynamics of Staphylococcus aureus strains in adults with cystic fibrosis (CF) Jonte, J.
 2007
 6 S1 p. S28-
1 p.
 article
106 149 Early warning signs of bacterial exacerbation in cystic fibrosis patients Jimenez, H.A.
 2007
 6 S1 p. S36-
1 p.
 article
107 324* Eating disorder symptomatology in cystic fibrosis before and after transplant: A case presentation Brager, N.
 2007
 6 S1 p. S79-
1 p.
 article
108 273 Educational leaflets to improve use of volume space device in children with CF Sallort, M.
 2007
 6 S1 p. S67-
1 p.
 article
109 113 Effect of a segregation policy on the incidence of multi-resistant Pseudomonas aeruginosa (mrPA) in adult patients with cystic fibrosis (CF) Clifton, I.
 2007
 6 S1 p. S28-
1 p.
 article
110 258* Effect of global posture reeducation (GPR) program on respiratory muscle strength Buonpensiero, P.
 2007
 6 S1 p. S64-
1 p.
 article
111 130 Effect of hypertonic saline on Exhaled Breath Condensate Hansen, C.R.
 2007
 6 S1 p. S32-
1 p.
 article
112 37 Effect of mist tent on ion content of nasal fluid in patients with cystic fibrosis Kozlova, I.
 2007
 6 S1 p. S8-
1 p.
 article
113 307 Effects of a clinic-based intervention on caregiving stress for parents of children with CF McDonald, L.
 2007
 6 S1 p. S75-
1 p.
 article
114 287 Effects of a clinic-based intervention on knowledge and treatment skills for parents and young children with CF Cruz, I.
 2007
 6 S1 p. S70-
1 p.
 article
115 138 Effects of antibiotic treatment of initial Pseudomonas aeruginosa colonization on acquisition of chronic infection in cystic fibrosis Fustik, S.
 2007
 6 S1 p. S33-
1 p.
 article
116 401 Effects of disease progression on peripheral muscle strength and bulk, aerobic capacity and physical activity in cystic fibrosis (CF) Opdekamp, C.
 2007
 6 S1 p. S98-
1 p.
 article
117 319 Effects of maternal depression on electronically monitored enzyme adherence and changes in weight for children with CF Quittner, A.L.
 2007
 6 S1 p. S78-
1 p.
 article
118 298 Efficacy of educational intervention to practice hygiene measures at routine clinic visits Armoni, S.
 2007
 6 S1 p. S73-
1 p.
 article
119 389 Efficacy of home versus hospital-administered intravenous antibiotics in cystic fibrosis Termoz, A.
 2007
 6 S1 p. S95-
1 p.
 article
120 83 Emergence of an epidemic clone of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) Panton-Valentine leukocidin (PVL) negative in Cystic Fibrosis patients Cocchi, P.
 2007
 6 S1 p. S20-
1 p.
 article
121 351* Employment status of cystic fibrosis adults–a10year improving picture Gunn, E.
 2007
 6 S1 p. S85-
1 p.
 article
122 213* Energy and nutrient intakes of paediatric subjects with cystic fibrosis (CF) Corridon, C.
 2007
 6 S1 p. S52-
1 p.
 article
123 219 Energy intake from PEG feeds and long-term anthropometric changes in children with CF Hopkins, D.
 2007
 6 S1 p. S54-
1 p.
 article
124 207* Essential fatty acid (EFA) profile in CF patients with ‘severe’ and ‘mild’ mutations De Boeck, K.
 2007
 6 S1 p. S50-
1 p.
 article
125 403 Estimating the age of common CFTR mutations in Brittany (western France) Fichou, Y.
 2007
 6 S1 p. S98-
1 p.
 article
126 246 EUR-1008 (a new pancraetic enzyme product, PEP) was shown to be safe and effective in cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI) Heubi, J.E.
 2007
 6 S1 p. S61-
1 p.
 article
127 224 Evaluating knowledge about nutrition in CF adult patients Lahoreau, D.
 2007
 6 S1 p. S55-
1 p.
 article
128 347 Evaluation and evolution of the national Belgian CF database Jansen, H.
 2007
 6 S1 p. S84-
1 p.
 article
129 111* Evaluation of anti-A-band LPS antibodies to Pseudomonas aeruginosa in serum from patients with cystic fibrosis Weisner, A.M.
 2007
 6 S1 p. S27-
1 p.
 article
130 68* Evaluation of new guidelines for the eradication of Staphylococcus aureus in children with cystic fibrosis Aldag, I.
 2007
 6 S1 p. S17-
1 p.
 article
131 371 Evaluation of nonclassic CF: interpretation of sweat test methods in correlation to ICM and CFTR genotype Derichs, N.
 2007
 6 S1 p. S91-
1 p.
 article
132 399 Evaluation of urinary incontinence in girls and female adolescents with cystic fibrosis Van Schaijk, M.
 2007
 6 S1 p. S97-
1 p.
 article
133 204 Evolution of glucose intolerance in adolescent CF patients Carpenter, S.
 2007
 6 S1 p. S50-
1 p.
 article
134 256* Exercise capacity, muscle strength and quality of life in adult CF patients Vrijsen, B.
 2007
 6 S1 p. S63-
1 p.
 article
135 172 Exhaled nitric oxide is not correlated with inflammation in Cystic Fibrosis Hatziagorou, E.
 2007
 6 S1 p. S42-
1 p.
 article
136 124* Exhaled NO and exhaled breath condensate in patients with cystic fibrosis and healthy controls Bloemen, K.
 2007
 6 S1 p. S31-
1 p.
 article
137 355 Family testing: the 17-year experience of Brittany (western France) Duguépéroux, I.
 2007
 6 S1 p. S87-
1 p.
 article
138 374 18FDG-PET/CT in CF: correlation with both inflammatory markers and FEV1 Cohen-Cymberknoh, M.
 2007
 6 S1 p. S91-
1 p.
 article
139 337 Feasibility and tolerance of percutaneous central catheters in children with cystic fibrosis (CF) Bui, S.
 2007
 6 S1 p. S82-
1 p.
 article
140 36 Feasibility of airway surface liquid (ASL) height measurement in human nasal and bronchial biopsies Griesenbach, U.
 2007
 6 S1 p. S8-
1 p.
 article
141 141 FEV1% predicted may not be a simple end point for CF studies Goldman, M.H.
 2007
 6 S1 p. S34-
1 p.
 article
142 49 Flavonoid-serum-levels in patients with cystic fibrosis Schüler, D.
 2007
 6 S1 p. S12-
1 p.
 article
143 170 Following of lung transplantation for CF patients in Hungary Kelemen, K.
 2007
 6 S1 p. S41-
1 p.
 article
144 71 Follow-up of P. aeruginosa eradication in CF patients by RAPD analysis Ravenni, N.
 2007
 6 S1 p. S17-
1 p.
 article
145 Foreword Göçmen, Ayhan
 2007
 6 S1 p. v-
1 p.
 article
146 142 Frequency of sputum sampling in an adult CF outpatient clinic:How much is too much? Boyle, L.R.
 2007
 6 S1 p. S34-
1 p.
 article
147 159 Fundoplication for reflux induced cough in cystic fibrosis Haley, N.M.
 2007
 6 S1 p. S39-
1 p.
 article
148 199 Gallbladder anomalies among children with CF Ciuca Popa, I.M.
 2007
 6 S1 p. S48-
1 p.
 article
149 301 Gender differences in life satisfaction of adolescent and adult patients with cystic fibrosis Besier, T.
 2007
 6 S1 p. S74-
1 p.
 article
150 19 Gene therapy for CF: a survey of patients' knowledge and opinions Thomas, A.
 2007
 6 S1 p. S5-
1 p.
 article
151 110 Genetic fingerprinting of Pseudomonas aeruginosa (PA) from Italian CF patients (pts): comparison with isolates from environment and other clinical origins in Europe Manno, G.
 2007
 6 S1 p. S27-
1 p.
 article
152 13 Genetic markers of musculoskeletal changes in cystic fibrosis Norek, A.
 2007
 6 S1 p. S3-
1 p.
 article
153 395 Genital human papillomavirus (HPV) infection and its consequences in CF lung transplant (tx) recipients Knoop, C.
 2007
 6 S1 p. S96-
1 p.
 article
154 105 Genomic fingerprinting of Pseudomonas aeruginosa isolates from all Swedish CF Centres. A Scandinavian Cystic Fibrosis Study Consortium study Johansson, E.
 2007
 6 S1 p. S26-
1 p.
 article
155 103 Genotype diversity of P. aeruginosa in CF sputum samples Waine, D.J.
 2007
 6 S1 p. S25-
1 p.
 article
156 109 Genotyping of P. aeruginosa, A. xylosoxidans and S. maltophilia in a CF centre Van daele, S.
 2007
 6 S1 p. S27-
1 p.
 article
157 329 Gift of life: Young adult lung transplant recipients talk about their new lungs Ullrich, G.
 2007
 6 S1 p. S80-
1 p.
 article
158 16* Glutathione S-transferase activity-genotype association with time and severity of Pseudomonas aeruginosa lung infection in cystic fibrosis children Feuillet-Fieux, M.N.
 2007
 6 S1 p. S4-
1 p.
 article
159 289 Group work as a coping skill for children with CF, ages 9–12 Amitzur, M.
 2007
 6 S1 p. S71-
1 p.
 article
160 7 GT repetition on 5T allele Maschio, M.
 2007
 6 S1 p. S2-
1 p.
 article
161 229 Hand grip strength values correlate with recognised outcome measures in a cohort of adult CF patients Al Siaidi, J.
 2007
 6 S1 p. S56-
1 p.
 article
162 237 Hand radiograms as an alternative for dual X-ray absorptiometry in bone mass assessment in cystic fibrosis patients? Tomalak, W.
 2007
 6 S1 p. S58-
1 p.
 article
163 69 Healthcare costs of infection with the major transmissible UK Pseudomonas aeruginosa strain, LES Spencer-Clegg, E.
 2007
 6 S1 p. S17-
1 p.
 article
164 94 High bacterial diversity of Staphylococcus aureus populations in airway specimens of cystic fibrosis patients Goerke, C.
 2007
 6 S1 p. S23-
1 p.
 article
165 252 High frequency chest wall oscillation: an adjunct to other airway clearance techniques in CF adults? Gumery, L.
 2007
 6 S1 p. S62-
1 p.
 article
166 154 Home monitoring using portable spirometry and SMS reminder service in CF Desager, K.N.
 2007
 6 S1 p. S37-
1 p.
 article
167 332* How to improve the daily management of implantable catheter ports (ICP)? Proposal of a practical tool for nurses and physicians Dupont, C.
 2007
 6 S1 p. S81-
1 p.
 article
168 268 Hygiene of the inhalation equipment: a Belgian national survey Reychler, G.
 2007
 6 S1 p. S66-
1 p.
 article
169 267 Hygiene of the inhalation equipment: what about vibrating-mesh nebulizers? Lessire, F.
 2007
 6 S1 p. S66-
1 p.
 article
170 100 Identification algorithms for Burkholderia cepacia complex bacteria Vanlaere, E.
 2007
 6 S1 p. S25-
1 p.
 article
171 17 Identification of a de novo mRNA molecular defect in a CF patient Audrezet, M.P.
 2007
 6 S1 p. S4-
1 p.
 article
172 117 Identification of airborne fungi in an adult CF unit Nagano, Y.
 2007
 6 S1 p. S29-
1 p.
 article
173 2* Identification of two Alu insertions in the CFTR gene Audrezet, M.P.
 2007
 6 S1 p. S1-
1 p.
 article
174 121 Immunoglobulin levels in cystic fibrosis patients: influence of age and gender Hanssens, L.
 2007
 6 S1 p. S30-
1 p.
 article
175 381 Impact of practice guidelines on the activity of cystic fibrosis centres Decullier, E.
 2007
 6 S1 p. S93-
1 p.
 article
176 77* Impact of reducing routine sensitivity testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis Etherington, C.
 2007
 6 S1 p. S19-
1 p.
 article
177 210 Importance of CF-formula in the nutrition of children with cystic fibrosis Sands, D.
 2007
 6 S1 p. S52-
1 p.
 article
178 266 Improved pulmonary function and quality of life perception after respiratory training with a specific commercial device Sartori, R.
 2007
 6 S1 p. S66-
1 p.
 article
179 306 Improving the quality of life for CF patients by facilitating their creativity Chladova, H.
 2007
 6 S1 p. S75-
1 p.
 article
180 177 Incidence and evolution of nasal polyposis in cystic fibrosis children and adolescents Weber, S.A.
 2007
 6 S1 p. S43-
1 p.
 article
181 352 Incidence and evolution of nasal polyposis in cystic fibrosis children and adolescents Weber, S.A.
 2007
 6 S1 p. S85-
1 p.
 article
182 206 Incidence of nephrocalcinosis and hypercalciuria in Turkish cystic fibrosis children Pekcan, S.
 2007
 6 S1 p. S50-
1 p.
 article
183 200 Inflammatory cytokines and markers of bone metabolism during CF infective exacerbations Shead, E.F.
 2007
 6 S1 p. S49-
1 p.
 article
184 240 Influence of pancreatic status on plasma and erythrocyte membrane fatty acid composition in CF Coste, T.C.
 2007
 6 S1 p. S59-
1 p.
 article
185 167 Inhalation with PARI eFlow® rapid reduces treatment burden significantly in adult CF patients without altering lung function Fischer, R.
 2007
 6 S1 p. S41-
1 p.
 article
186 70 Initial colonization with Pseudomonas aeruginosa in cystic fibrosis: preliminary results of an eradication protocol Adde, F.V.
 2007
 6 S1 p. S17-
1 p.
 article
187 367 Intestinal current measurement as a diagnostic procedure in cystic fibrosis in infants and young children Wilschanski, M.
 2007
 6 S1 p. S90-
1 p.
 article
188 135 Intravenous antibiotic treatment in children with cystic fibrosis: home versus hospital setting Proesmans, M.
 2007
 6 S1 p. S33-
1 p.
 article
189 382* Introduction & evaluation of a pharmacist-run medication review for cystic fibrosis patients Philpott, L.
 2007
 6 S1 p. S93-
1 p.
 article
190 178 Introduction of dual energy X-ray absorptiometry into the annual review of adult cystic fibrosis patients at All Wales Adult Regional Centre, UK Palamarthy, A.B.
 2007
 6 S1 p. S43-
1 p.
 article
191 223 Inverse gender gap in nutritional status; Scandinavian CF study consortium Olesen, H.V.
 2007
 6 S1 p. S55-
1 p.
 article
192 232* Is puberty delayed in cystic fibrosis? Panagopoulou, P.
 2007
 6 S1 p. S57-
1 p.
 article
193 52 Joint effect of alpha-melanocyte stimulating hormone and met-enkephalin on respiratory function in guinea-pigs T-Drinkovic, D.
 2007
 6 S1 p. S13-
1 p.
 article
194 300 Keeping CF kids connected – Ability Online Taylor, L.
 2007
 6 S1 p. S73-
1 p.
 article
195 86* Lactate production and Pseudomonas aeruginosa metabolism in CF sputum Worlitzsch, D.
 2007
 6 S1 p. S21-
1 p.
 article
196 6* Large CFTR gene rearrangements in Italian population Paracchini, V.
 2007
 6 S1 p. S2-
1 p.
 article
197 44 Lentiviral vector-mediated expression of RNA interference for ENaC in cell models of airway epithelium suitable for functional evaluation of ENaC activity Copreni, E.
 2007
 6 S1 p. S11-
1 p.
 article
198 43 Lentiviral vector-mediated expression of RNA interference sequences for ENaC in cell models of human airway epithelium Copreni, E.
 2007
 6 S1 p. S10-
1 p.
 article
199 67 Linezolid-induced neurological adverse effects after prolonged treatment for MRSA respiratory infections in CF De Wachter, E.
 2007
 6 S1 p. S16-
1 p.
 article
200 402 Lip enlargement as a clinical feature of cystic fibrosis Cakic, S.S.
 2007
 6 S1 p. S98-
1 p.
 article
201 196 Liver transplantation in children with cystic fibrosis: single centre experience Loganathan, S.
 2007
 6 S1 p. S47-
1 p.
 article
202 312 Living with Cystic Fibrosis Questionnaire (CFLC-Q): Development and preliminary validation of a new measure of the challenge experienced by caregivers Glasscoe, C.
 2007
 6 S1 p. S76-
1 p.
 article
203 190 Long-term outcome after meconium ileus Kappler, M.
 2007
 6 S1 p. S46-
1 p.
 article
204 129 Long-term treatment with glucocorticoids in low doses restores affected cytokine production in cystic fibrosis patients Pukhalsky, A.L.
 2007
 6 S1 p. S32-
1 p.
 article
205 384 Long-term treatment with Pulmozyme® is associated with slower rate or improvement of lung functions decline in CF patients Kayserova, H.
 2007
 6 S1 p. S94-
1 p.
 article
206 51 Lung deposition and pharmacokinetics in 12 lung transplanted patients after inhalation of a liposomal Ciclosporin A (CsA) formulation by the eFlow electronic nebuliser Keller, M.
 2007
 6 S1 p. S12-
1 p.
 article
207 163* Lung disease progression in children with cystic fibrosis Terheggen/Lagro, S.W.
 2007
 6 S1 p. S40-
1 p.
 article
208 156* Lung function in children with CF – from infants to seven years old Geborek, A.
 2007
 6 S1 p. S38-
1 p.
 article
209 193 Major differences in pancreatic enzyme replacement in Scandinavia Hjelte, L.
 2007
 6 S1 p. S47-
1 p.
 article
210 397 Malignant disease adults with cystic fibrosis: a 10 year review Khan, Z.
 2007
 6 S1 p. S97-
1 p.
 article
211 388 May peripherally inserted central catheters (PICC) be an alternative for implantable catheter ports (ICP) for intravenous (IV) antibiotic therapy? Dupont, C.
 2007
 6 S1 p. S95-
1 p.
 article
212 288 Mediating and negotiating and in-patient stay for families and patients with cystic fibrosis Latage, K.
 2007
 6 S1 p. S70-
1 p.
 article
213 82 Methicillin-resistant Staphylococcus aureus from airway secretions from patients with cystic fibrosis Alexandrou-Athanasoulis, H.
 2007
 6 S1 p. S20-
1 p.
 article
214 205 Microalbuminuria in patients with cystic fibrosis: diabetic or cystic fibrosis-related? Kannekens, A.L.
 2007
 6 S1 p. S50-
1 p.
 article
215 96 Microbiological audit in Cystic Fibrosis Romanian children Popa, I.
 2007
 6 S1 p. S24-
1 p.
 article
216 12* Modulatory effect of MBL2 on the onset of Pseudomonas aeruginosa infection is influenced by the TGFβ1 variants in pediatric CF patients Dorfman, R.
 2007
 6 S1 p. S3-
1 p.
 article
217 104 Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients Spasenovski, T.
 2007
 6 S1 p. S26-
1 p.
 article
218 25* Molecular and functional characterization of CBAVD-causing mutations located in both NBDs of the CFTR protein Grangeia, A.
 2007
 6 S1 p. S6-
1 p.
 article
219 157 Monitoring of Dornase alfa treatment efficacy for children with cystic fibrosis Dumcius, S.
 2007
 6 S1 p. S38-
1 p.
 article
220 363 Monthly variation in newborn screening immunoreactive trypsinogen concentrations [IRT] Montgomery, M.D.
 2007
 6 S1 p. S89-
1 p.
 article
221 102 Morbidity of a peadiatric population with CF, according to chronic P. aeruginosa (Pa) colonization Sad, I.
 2007
 6 S1 p. S25-
1 p.
 article
222 120* Multiplex cytokine profile detection in young children with cystic fibrosis Terheggen-Lagro, S.
 2007
 6 S1 p. S30-
1 p.
 article
223 146 Mycobacterium abscessus infection in lung transplant patients: Review of our series Morales, P.
 2007
 6 S1 p. S35-
1 p.
 article
224 369* Nasal potential difference in hypertrypsinemic children Sermet-Gaudelus, I.
 2007
 6 S1 p. S90-
1 p.
 article
225 368 Nasal potential difference testing in the diagnostic algorithm of CF Middleton, P.G.
 2007
 6 S1 p. S90-
1 p.
 article
226 118 Navigating microbial space using the StrainInfo.net bioportal Van Brabant, B.
 2007
 6 S1 p. S29-
1 p.
 article
227 48* Nebulized SLIT™ Amikacin in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection in Serbia and Hungary Mackinson, C.
 2007
 6 S1 p. S12-
1 p.
 article
228 359 Negative genetic neonatal screening for cystic fibrosis caused by compound heterozygosity for two large CFTR rearrangements Guittard, C.
 2007
 6 S1 p. S88-
1 p.
 article
229 366 Neonatal cystic fibrosis screening in Russian Federation Tolstova, V.D.
 2007
 6 S1 p. S89-
1 p.
 article
230 364 Newborn screening in the Czech Republic: an effective tool for early detection of CF Zemkova, D.
 2007
 6 S1 p. S89-
1 p.
 article
231 356 Newborn screening (NBS) facilitates diagnosis of previously unrecognised CF in older siblings Skalicka, V.
 2007
 6 S1 p. S87-
1 p.
 article
232 270 New nebulisers and colistin-resistant Pseudomonas aeuginosa (crPA) in patients with cystic fibrosis (CF) Hurlow, A.
 2007
 6 S1 p. S67-
1 p.
 article
233 158 Nocturnal cough frequency in children with cystic fibrosis van der Giessen, L.J.
 2007
 6 S1 p. S38-
1 p.
 article
234 155* Noninvasive evaluation of pulmonary disease using volumetric capnography in adult patients with cystic fibrosis Paschoal, I.A.
 2007
 6 S1 p. S38-
1 p.
 article
235 175 Noninvasive ventilation (NIV) in cystic fibrosis patients (CF) with past pneumothorax (PNX): a case report Casciaro, R.
 2007
 6 S1 p. S43-
1 p.
 article
236 214 Nutritional assessment of three groups of paediatric subjects with cystic fibrosis (CF), classified according to normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and cystic fibrosis related diabetes (CFRD) Caffrey, J.M.
 2007
 6 S1 p. S53-
1 p.
 article
237 225 Nutritional status and dietary intake in patients with cystic fibrosis Spirevska, L.
 2007
 6 S1 p. S55-
1 p.
 article
238 291* Nutrition education program in cystic fibrosis children Cazenave-Givelet, A.
 2007
 6 S1 p. S71-
1 p.
 article
239 220 Obesity in childhood cystic fibrosis Stack, M.
 2007
 6 S1 p. S54-
1 p.
 article
240 73* Occurrence of P. aeruginosa (PA) with hypermutable phenotype (HPM) in Italian CF patients Manno, G.
 2007
 6 S1 p. S18-
1 p.
 article
241 185 Oesophagitis, gastritis, duodenitis, hiatus hernia and Barrett's oesophagus in adults with cystic fibrosis Button, B.M.
 2007
 6 S1 p. S45-
1 p.
 article
242 108 Only a subset of Pseudomonas aeruginosa strains is able to colonize CF patients Vaneechoutte, M.
 2007
 6 S1 p. S27-
1 p.
 article
243 244 On which foods can pancreatic enzyme preparations (PEPs) be sprinkled? Shepherd, D.
 2007
 6 S1 p. S60-
1 p.
 article
244 33* Optical imaging of calcium-evoked fluid secretion by murine airway submucosal gland serous acinar cells Lee, R.J.
 2007
 6 S1 p. S7-
1 p.
 article
245 372* Outcome of the pregnancies with an echogenic bowel detected by ultrasonography: the 15 year-experience of Brittany (western France) Scotet, V.
 2007
 6 S1 p. S91-
1 p.
 article
246 243 Overfilling in pancreatic enzyme preparations: still an unresolved issue Foresti, R.
 2007
 6 S1 p. S60-
1 p.
 article
247 127* Oxidative stress activates ERK1/2 but no NF-κB signalling in CFTR-deficient bronchial epithelial cells Boncoeur, E.
 2007
 6 S1 p. S31-
1 p.
 article
248 194 Pancreatitis in cystic fibrosis patients Sojo, A.
 2007
 6 S1 p. S47-
1 p.
 article
249 295 Parents' perceptions and recommendations for follow-up of newborn screening Semple, L.K.
 2007
 6 S1 p. S72-
1 p.
 article
250 336 Patient assessment of a new intravenous infusion device Catling, T.
 2007
 6 S1 p. S82-
1 p.
 article
251 215 Patient satisfaction and staff perceptions of food provision on an adult CF unit following segregation Watson, H.
 2007
 6 S1 p. S53-
1 p.
 article
252 286 Perceptions of young people with CF on the lack of knowledge and understanding of the condition within the general public Hogan, J.
 2007
 6 S1 p. S70-
1 p.
 article
253 276 Perception versus objective assessment of diseases severity in cohort adult cystic fibrosis (CF) patients Douglass, H.
 2007
 6 S1 p. S68-
1 p.
 article
254 75 Persistence of metallo-β–lactamase-producing Pseudomonas aeruginosa in cystic fibrosis patients Campana, S.
 2007
 6 S1 p. S18-
1 p.
 article
255 50 Pharmacokinetic comparison of inhaled tobramycin (TOBI®) via PARI eFlow® rapid or PARI LC Plus™ nebulizers in cystic fibrosis patients Hubert, D.
 2007
 6 S1 p. S12-
1 p.
 article
256 65 Pharmacokinetics of Azithromycin during once weekly dosing in cystic fibrosis patients Wilms, E.B.
 2007
 6 S1 p. S16-
1 p.
 article
257 61* Photodynamic therapy against antibiotic resistant Pseudomonas aeruginosa isolates from CF patients Torun, O.Y.
 2007
 6 S1 p. S15-
1 p.
 article
258 262 Physiological responses of cardiovascular and muscle endurance in cystic fibrosis patients Arikan, H.
 2007
 6 S1 p. S65-
1 p.
 article
259 309 Piloting the use of the cystic fibrosis questionnaire (CFQ) in CF patients changing to dry powder inhaled colistimethate Conway, S.P.
 2007
 6 S1 p. S76-
1 p.
 article
260 239 Pilot study for evaluation of essential fatty acids deficiency in Slovak CF patients Sabolova, G.
 2007
 6 S1 p. S59-
1 p.
 article
261 217 Placement and replacement of gastrostomies under general anaesthetic in adults with cystic fibrosis (CF) Chinuck, R.S.
 2007
 6 S1 p. S53-
1 p.
 article
262 85* Plant host and sugar alcohol induced exopolysaccharide biosynthesis in the Burkholderia cepacia complex Bartholdson, J.
 2007
 6 S1 p. S21-
1 p.
 article
263 64 Population pharmacokinetics (PK) of tobramycin administered thrice daily (TD) and once daily (OD) in children and adults with CF Touw, D.J.
 2007
 6 S1 p. S16-
1 p.
 article
264 161 PortaNeb® or CR60®? Inhalation of tobramycin (TOBI®) with the Pari LC Plus® nebuliser: an in vivo pilot study Westerman, E.M.
 2007
 6 S1 p. S39-
1 p.
 article
265 62 Potential use of photodynamic antimicrobial therapy for treatment of Pseudomonas aeruginosa Cystic Fibrosis pulmonary infection Donnelly, R.F.
 2007
 6 S1 p. S15-
1 p.
 article
266 45* Preclinical evidence that sildenafil corrects cystic fibrosis defects Lubamba, B.
 2007
 6 S1 p. S11-
1 p.
 article
267 303 Predicting change in depression for parents of children with CF: health and demographic factors Kinnamon, C.
 2007
 6 S1 p. S74-
1 p.
 article
268 173 Predictive factors of sleep hypoxemia in children with cystic fibrosis Uyan, Z.S.
 2007
 6 S1 p. S42-
1 p.
 article
269 209 Pregnancy in lung transplant recipients in France Hubert, D.
 2007
 6 S1 p. S51-
1 p.
 article
270 392* Preliminary results of motivation program for CF patients “LifeClubCF” Krzyzanowski, M.
 2007
 6 S1 p. S96-
1 p.
 article
271 186 Presence of weakly acidic reflux and gastric aspiration in adult patients with CF Blondeau, K.
 2007
 6 S1 p. S45-
1 p.
 article
272 150 Prevalence of nontuberculous mycobacteria in a Czech Cystic Fibrosis centre Holcikova, A.
 2007
 6 S1 p. S36-
1 p.
 article
273 122 Pro-inflammatory cytokines in serum, sputum and lavage fluid (BALF) in cystic fibrosis lungs Bulgakova, T.V.
 2007
 6 S1 p. S30-
1 p.
 article
274 32* Pro-inflammatory effects of sodium 4-phenylbutyrate in CF lung epithelial cells containing F508del-CFTR Roque, T.
 2007
 6 S1 p. S7-
1 p.
 article
275 164 Pseudomonas aeruginosa in children with cystic fibrosis Laurans, M.
 2007
 6 S1 p. S40-
1 p.
 article
276 148 Pseudomonas aeruginosa infection: utility of microbiological, PCR-based and serological techniques Brazova, J.
 2007
 6 S1 p. S36-
1 p.
 article
277 114 Pseudomonas aeruginosa transmission at a winter camp in spite of rigorous precautions Meyer, P.
 2007
 6 S1 p. S28-
1 p.
 article
278 340 Psychopathological overview of adolescents with cystic fibrosis (CF) Kirszenbaum, M.
 2007
 6 S1 p. S83-
1 p.
 article
279 328* Psychosocial case study: infant diagnosed with CF through newborn screening Tluczek, A.
 2007
 6 S1 p. S80-
1 p.
 article
280 41* PTC124 activity in CF patients carrying stop mutations: results of a phase 2 study Kerem, E.
 2007
 6 S1 p. S10-
1 p.
 article
281 360 Pulmonary and nutritional outcomes in children with cystic fibrosis (CF) detected through neonatal screening and by symptoms in Argentina D'Alessandro, V.
 2007
 6 S1 p. S88-
1 p.
 article
282 361 Pulmonary function in infants with cystic fibrosis (CF) detected through neonatal screening and by symptoms in Argentina D'Alessandro, V.
 2007
 6 S1 p. S88-
1 p.
 article
283 174 Pulmonary mechanics in cystic fibrosis (CF) patients awaiting lung transplantation. Evaluation of non invasive mechanical ventilation (NIV) Tardivo, I.
 2007
 6 S1 p. S42-
1 p.
 article
284 255* Pulmonary rehabilitation following lung transplantation Munro, P.
 2007
 6 S1 p. S63-
1 p.
 article
285 302 Quality of life and anxious and depressive symptoms in mothers of children with CF Driscoll, K.A.
 2007
 6 S1 p. S74-
1 p.
 article
286 275 Questionnaire survey of stress urinary incontinence (UI) in 9–16 year olds with cystic fibrosis, compared to other chronic respiratory conditions and a normal group Browne, W.J.
 2007
 6 S1 p. S68-
1 p.
 article
287 47 Reactive airway disease and cystic fibrosis: a retrospective analysis of the safety and tolerability with denufosol inhalation solution Rossi, A.
 2007
 6 S1 p. S11-
1 p.
 article
288 38 Reduction of activity of Arylsulfatasi B in patient with Cystic Fibrosis Pagliardini, S.
 2007
 6 S1 p. S9-
1 p.
 article
289 326 Referrals to a new adult CF psychology service Lamb, D.
 2007
 6 S1 p. S79-
1 p.
 article
290 238 Relation between fatty acid (FA) composition and clinical status/genotype in CF? Van Biervliet, S.
 2007
 6 S1 p. S59-
1 p.
 article
291 152 Relationship between HRCT score, lung function and clubbing in patients with cystic fibrosis (CF) Clifton, I.
 2007
 6 S1 p. S37-
1 p.
 article
292 265 Relationship between nutritional status and muscle strength in patients with cystic fibrosis (CF) Bosnak-Guclu, M.
 2007
 6 S1 p. S65-
1 p.
 article
293 257 Relationship between upper limb muscle strength and functional capacity in patients with cystic fibrosis (CF) Ozturk, M.
 2007
 6 S1 p. S63-
1 p.
 article
294 398 Renal function in relation to age in cystic fibrosis Giourtzis, S.
 2007
 6 S1 p. S97-
1 p.
 article
295 72 Repeated Eradications of Pseudomonas aeruginosa in Cystic Fibrosis Patients Taccetti, G.
 2007
 6 S1 p. S18-
1 p.
 article
296 31 Rescue of deltaF508 CFTR in CFBE41o- cells is dependent on actin cytoskeleton interaction with ezrin and NHERF1 Guerra, L.
 2007
 6 S1 p. S7-
1 p.
 article
297 391 Residential deprivation has no adverse effects on clinical parameters in adult CF patients Youzguin, A.
 2007
 6 S1 p. S95-
1 p.
 article
298 373* Respiratory exacerbations in childhood associated with compound heterozygote CFTR genotype ΔF508/R117H on a background of 7T polythymidine tract at intron 8 Lee, T.W.
 2007
 6 S1 p. S91-
1 p.
 article
299 226 Resting energy expenditure and nutritional status pre and post lung transplantation Kalnins, D.
 2007
 6 S1 p. S56-
1 p.
 article
300 18* Restoration of the CFTR function by splicing modulation Nissim-Rafinia, M.
 2007
 6 S1 p. S5-
1 p.
 article
301 274* RhDNase before or after going to sleep in children with cystic fibrosis? van der Giessen, L.J.
 2007
 6 S1 p. S68-
1 p.
 article
302 169 Risk factors for bronchiolitis obliterans syndrome (BOS) after double lung transplantation for cystic fibrosis (CF): 10-year experience Quattrucci, S.
 2007
 6 S1 p. S41-
1 p.
 article
303 66 Safety of oral choramphenicol for pseudomonas aeruginosa infections in cystic fibrosis Orchard, C.D.
 2007
 6 S1 p. S16-
1 p.
 article
304 272 Satisfaction survey concerning vibrating mesh-nebulizer in CF patients Reychler, G.
 2007
 6 S1 p. S67-
1 p.
 article
305 116 Scedosporium apiospermum. Environmental study in the homes of patients with cystic fibrosis Sidot, C.
 2007
 6 S1 p. S29-
1 p.
 article
306 335 Segregation of children with cystic fibrosis: difference in psychosocial impact between young children and adolescents Keizer, F.
 2007
 6 S1 p. S82-
1 p.
 article
307 99 Sensitivity of recA PCR for direct detection of Burkholderia cepacia complex (BCC) from sputum of CF patients Ergunay, K.
 2007
 6 S1 p. S24-
1 p.
 article
308 394 Seroconversion after Hepatitis B (HB) and Hepatitis A (HA) vaccination in CF patients (pts) De Schutter, I.
 2007
 6 S1 p. S96-
1 p.
 article
309 235 Serum vitamin E and IL-6 are influenced by type of physical training in patients with CF Sahlberg, M.
 2007
 6 S1 p. S58-
1 p.
 article
310 236 Serum zinc concentrations of the CF population above the age of 4 years: a cross-sectional evaluation Van Biervliet, S.
 2007
 6 S1 p. S58-
1 p.
 article
311 390 Socio-economic deprivation in the North West of England predicts work status in adult cystic fibrosis patients Youzguin, A.
 2007
 6 S1 p. S95-
1 p.
 article
312 3* Spectrum of CFTR mutations in a group of black patients from South Africa: Identification of a novel large rearrangement des Georges, M.
 2007
 6 S1 p. S1-
1 p.
 article
313 126 Sphingomyelinase and ceramidase activities in tissues of delta-F508 CFTR mice Olsson, L.
 2007
 6 S1 p. S31-
1 p.
 article
314 234 Status of fat soluble vitamins in Scandinavian CF patients Nilsson, K.
 2007
 6 S1 p. S58-
1 p.
 article
315 87 Strict anaerobes persist in CF sputum despite antibiotic treatment Worlitzsch, D.
 2007
 6 S1 p. S21-
1 p.
 article
316 28* Study of the unfolded protein response (UPR) in cystic fibrosis (CF) Kerbiriou, M.
 2007
 6 S1 p. S6-
1 p.
 article
317 128 Supplementation with n-3 PUFA in CF patients: analysis of exhaled breath condensate Fila, L.
 2007
 6 S1 p. S32-
1 p.
 article
318 269 Survey of the contamination of home nebulizers of cystic fibrosis patients and assessment of the implementation of a standardised recommendation Reychler, G.
 2007
 6 S1 p. S66-
1 p.
 article
319 357 Survey of the information provided for parents about newborn screening for CF in European programmes Munck, A.
 2007
 6 S1 p. S87-
1 p.
 article
320 345* Survival factors in cystic fibrosis: a case-control study Simmonds, N.J.
 2007
 6 S1 p. S84-
1 p.
 article
321 101* Survival of Cepacia Syndrome Kassim, I.
 2007
 6 S1 p. S25-
1 p.
 article
322 376 Sweat test results on a suspected cystic fibrosis population with CF mutation analysis and the frequency of borderline results Tanyalcin, T.
 2007
 6 S1 p. S92-
1 p.
 article
323 330 Telephone calls received by CF nurse specialists – best use of a scarce resource? Miller, H.
 2007
 6 S1 p. S80-
1 p.
 article
324 299* Ten years' of experience in patient education of families with a child/adolescent suffering from cystic fibrosis Bregnballe, V.
 2007
 6 S1 p. S73-
1 p.
 article
325 327 The adult cystic fibrosis patient: education, sports and work de Vrankrijker, A.
 2007
 6 S1 p. S80-
1 p.
 article
326 76* The bacterial burden of the CF lung – Uncovering the black box Bjarnsholt, T.
 2007
 6 S1 p. S19-
1 p.
 article
327 348* The Belgian CF registry (BMR-RBM) Sevens, C.
 2007
 6 S1 p. S84-
1 p.
 article
328 216 The benefits to patients with cystic fibrosis of a dedicated dietician Kelly, V.
 2007
 6 S1 p. S53-
1 p.
 article
329 293 The CF family/teen teaching day – do the benefits outweigh the risks? Taylor, L.
 2007
 6 S1 p. S72-
1 p.
 article
330 112* The change in Pseudomonas status of CF patients in Merseyside, UK – how are we doing? Miller, H.
 2007
 6 S1 p. S28-
1 p.
 article
331 136 The degree of change in FEV1 and FVC after 2 weeks of intravenous antibiotics for severe pulmonary exacerbation in adult patients with cystic fibrosis Jarad, N.A.
 2007
 6 S1 p. S33-
1 p.
 article
332 259* The effect of maximal exercise on FEV1 in adult cystic fibrosis (CF) Turner, S.M.
 2007
 6 S1 p. S64-
1 p.
 article
333 201 The effect of vitamin D and calcium supplementation in children and adolescents with cystic fibrosis and low bone mineral density Hatziagorou, E.
 2007
 6 S1 p. S49-
1 p.
 article
334 277 The effects of musculoskeletal physiotherapy and massage on pain and ease of breathing in adults with cystic fibrosis Lee, A.L.
 2007
 6 S1 p. S68-
1 p.
 article
335 242 The impact of a referral pathway on management of CFRD Rezaie, M.
 2007
 6 S1 p. S60-
1 p.
 article
336 166 The impact of gender, pulmonary disease severity and presence of diabetes on azithromycin (AZ) benefit in cystic fibrosis (CF) Butler, M.
 2007
 6 S1 p. S40-
1 p.
 article
337 191 The impact of meconium ileus on the liver course of children with cystic fibrosis Cuny, C.
 2007
 6 S1 p. S46-
1 p.
 article
338 339 The role of acceptance in adolescents with cystic fibrosis Casier, A.
 2007
 6 S1 p. S83-
1 p.
 article
339 318 The role of parental supervision on medical adherence in adolescents with Cystic Fibrosis Modi, A.C.
 2007
 6 S1 p. S77-
1 p.
 article
340 144 The significance of complete pulmonary function test data in the respiratory exacerbation of cystic fibrosis Shoseyov, D.
 2007
 6 S1 p. S35-
1 p.
 article
341 195 The Stewart Ultrasound Score (SUSS): a new tool for quantitative assessment of CFLD Stewart, L.
 2007
 6 S1 p. S47-
1 p.
 article
342 338 The theory and practice of childhood attachment and family systems for disease outcomes and service utilisation in adult cystic fibrosis patients. Research findings from a mixed methodological study Sutherland, S.M.
 2007
 6 S1 p. S82-
1 p.
 article
343 228 The value of a non-invasive method to assess fat free mass in adult CF patients – correlation with outcome measures in a cohort of adult CF patients Al Siaidi, J.
 2007
 6 S1 p. S56-
1 p.
 article
344 261 The value of exercise training in severely ill adult CF patients Morris, A.
 2007
 6 S1 p. S64-
1 p.
 article
345 203 Three day continuous subcutaneous glucose monitoring (CSGM) in the clinical management of adult patients with CF and diabetes (CFRD) Watson, H.
 2007
 6 S1 p. S49-
1 p.
 article
346 1 Three novel CFTR mutations found in Turkish patients with cystic fibrosis Ulgenalp, A.
 2007
 6 S1 p. S1-
1 p.
 article
347 222* Too short but not too light – analysis of height and weight in a Belgian CF population Vermeulen, F.
 2007
 6 S1 p. S55-
1 p.
 article
348 358* Towards a consensus on the investigation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis Mayell, S.J.
 2007
 6 S1 p. S87-
1 p.
 article
349 34* Tracheal structure abnormalities in Cftr-/- knockout mice Bonvin, E.
 2007
 6 S1 p. S8-
1 p.
 article
350 27* Transcription factors: new therapeutic targets in cystic fibrosis lung disease? Rene, C.
 2007
 6 S1 p. S6-
1 p.
 article
351 181 Transition program for cystic fibrosis adult patients Lopes, C.
 2007
 6 S1 p. S44-
1 p.
 article
352 323 Transplantation and changes in importance of social support Matossian, A.
 2007
 6 S1 p. S79-
1 p.
 article
353 55* Treatment of CF sinonasal disease using a combination of surgical procedure and coblation, a new therapeutic approach Faict, H.
 2007
 6 S1 p. S13-
1 p.
 article
354 176 Treatment of recurrent pneumothorax in adult cystic fibrosis patients Cowperthwaite, C.
 2007
 6 S1 p. S43-
1 p.
 article
355 14 Tumor necrosis factor gene polymorphisms in cystic fibrosis patients Shmarina, G.V.
 2007
 6 S1 p. S4-
1 p.
 article
356 314 Turkish translation and validation of revised Cystic Fibrosis Questionnaire (CFQ-R) for children Yuksel, H.
 2007
 6 S1 p. S77-
1 p.
 article
357 349* Twenty years of care for CF adults in Czech Republic Fila, L.
 2007
 6 S1 p. S85-
1 p.
 article
358 334 Use of central venous catheters in people with cystic fibrosis in Italy Ballarin, S.
 2007
 6 S1 p. S81-
1 p.
 article
359 192 Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis and mutations analisis Ducasse, K.
 2007
 6 S1 p. S46-
1 p.
 article
360 383 Use of non-prescribed drugs in adult CF patients Burhan, H.
 2007
 6 S1 p. S93-
1 p.
 article
361 151* Use of the Northern X-Ray scoring system over time in adult CF patients Burhan, H.
 2007
 6 S1 p. S37-
1 p.
 article
362 63 Use of tigecycline to treat difficult respiratory pathogens in cystic fibrosis – early experiences Denton, M.
 2007
 6 S1 p. S15-
1 p.
 article
363 92* Using insertion sequences to determine gene function in epidemic Pseudomonas aeruginosa Kenna, D.T.
 2007
 6 S1 p. S23-
1 p.
 article
364 42* Validating assays on invasive airway samples as end-points for gene therapy trials. Davies, J.
 2007
 6 S1 p. S10-
1 p.
 article
365 311 Validity and responsiveness of CF-38 health status measure Scott, S.F.
 2007
 6 S1 p. S76-
1 p.
 article
366 227 Validity of the Tanita TBF-300M body composition analyser in children with cystic fibrosis van Oversteeg, R.M.
 2007
 6 S1 p. S56-
1 p.
 article
367 320 Variance between perception score and objective score in adult CF patients – What are the reasons for the difference? Dyer, J.
 2007
 6 S1 p. S78-
1 p.
 article
368 91 Variations in phenotype and virulence amongst isolates of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa Fothergill, J.L.
 2007
 6 S1 p. S22-
1 p.
 article
369 387 Vestibulotoxicity as a consequence of systemically administered tobramycin in Cystic Fibrosis patients Scheenstra, R.J.
 2007
 6 S1 p. S94-
1 p.
 article
370 54 Visualization of human sinus ventilation by radioactive Krypton using the PARI Sinus pulsating system Schuschnig, U.
 2007
 6 S1 p. S13-
1 p.
 article
371 405 Water mobility by 3D-MR imaging in normal and CFTR KO mouse trachea Kaplan, H.
 2007
 6 S1 p. S99-
1 p.
 article
372 294* West Midlands cystic fibrosis (CF) newborn screening training evaluation Nixon, W.S.
 2007
 6 S1 p. S72-
1 p.
 article
373 321 What do professionals think about adherence in CF? Cowlard, J.
 2007
 6 S1 p. S78-
1 p.
 article
                             373 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands